Silo Pharma, Inc. (NASDAQ:SILO) Short Interest Update

Silo Pharma, Inc. (NASDAQ:SILOGet Free Report) was the target of a large decline in short interest in the month of May. As of May 31st, there was short interest totalling 34,200 shares, a decline of 68.1% from the May 15th total of 107,200 shares. Based on an average trading volume of 242,600 shares, the short-interest ratio is presently 0.1 days. Currently, 1.0% of the shares of the company are sold short.

Silo Pharma Stock Performance

Shares of SILO traded up $0.10 during trading hours on Thursday, hitting $1.21. The stock had a trading volume of 606,806 shares, compared to its average volume of 191,810. The firm has a 50-day moving average price of $1.83 and a 200 day moving average price of $1.67. Silo Pharma has a fifty-two week low of $1.05 and a fifty-two week high of $3.05.

Silo Pharma (NASDAQ:SILOGet Free Report) last issued its quarterly earnings results on Monday, May 13th. The company reported ($0.28) EPS for the quarter. The company had revenue of $0.02 million during the quarter. Silo Pharma had a negative return on equity of 51.75% and a negative net margin of 4,992.30%.

Silo Pharma Company Profile

(Get Free Report)

Silo Pharma. Inc, a developmental stage biopharmaceutical company, develops traditional therapeutics and psychedelic medicine. Its lead program includes SPC-15, an intranasal drug targeting post-traumatic stress disorder (PTSD) and stress-induced anxiety disorders; and SP-26, a ketamine-based loaded implant indicated for fibromyalgia and chronic pain relief.

Featured Articles

Receive News & Ratings for Silo Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Silo Pharma and related companies with MarketBeat.com's FREE daily email newsletter.